Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea

Summary

The primary objective is to demonstrate rifaximin 200 milligrams (mg) tablets (test) and Xifaxan® 200 mg tablets (reference) are clinically bioequivalent with respect to the clinical cure rates when administered 3 times a day (TID) for 3 days in participants with travelers' diarrhea.

Timeline

Start

2016-01-06

Primary completion

2017-02-28

Completion

2017-02-28

Drugs

Indications